Rx PHARMASIST.CA
The Pharmasist newsletter

Stay current in
Canadian pharmacy.

Pharmacy news, practice updates and fresh perspectives—delivered to your inbox.

Keep your practice informed

  • Canadian pharmacy news

    Follow the developments shaping the profession.

  • Prescriber updates

    Stay informed about newly licensed Ontario physicians.

  • What's new on Pharmasist

    Explore new resources, tools and learning opportunities.

Free newsletter

A useful addition to your inbox.

We'll send a confirmation link first. Privacy policy

Ophthalmic corticosteroid (topical ocular glucocorticoid)

Loteprednol Etabonate

Alrex

Dosage form
Tablet
Available strengths
0.2% w/v
Drug class
Ophthalmic corticosteroid (topical ocular glucocorticoid)
Common brand
Alrex

Clinical overview. Loteprednol etabonate (Alrex) is a topical ophthalmic corticosteroid used for short-term relief of itching and redness caused by seasonal allergic conjunctivitis. It is applied as eye drops up to four times daily for no more than 14 days, with intraocular pressure monitoring recommended if treatment continues beyond 10 days.

Indication

Common therapeutic uses

  • Used for the temporary, short-term relief of the signs and symptoms (itching and redness) of seasonal allergic conjunctivitis.
  • Intended for short-term use only, generally no more than two weeks, under a physician's supervision following an eye examination.

Pregnancy

Risk assessment and monitoring considerations

  • Has not been studied in pregnant women, and animal studies showed evidence of fetal harm at high doses, so it should not be used in pregnancy unless the anticipated benefit to the mother clearly outweighs the potential risk to the fetus.
  • This is a precaution rather than a formal contraindication, but caution and physician guidance are advised given the lack of human data.

Breastfeeding

Infant exposure considerations

  • Should not be used in nursing mothers unless the benefit to the mother clearly outweighs the potential risk to the nursing child, since systemic corticosteroids are known to pass into breast milk and it is not established whether ophthalmic use produces measurable levels in milk.

Geriatrics

Dosing and tolerability considerations

  • Not recommended for use in patients over 65 years of age, as safety and effectiveness have not been established in this age group.

Pediatrics

Use in children and adolescents

  • Not recommended for use in children, as safety and effectiveness have not been studied in pediatric patients.

Dosage & Administration

Practical dosing and administration

  • The usual dose is one drop instilled into the affected eye(s) four times daily for up to 14 days.
  • Shake the bottle vigorously before each use.
  • If a dose is missed, wait until the next scheduled dose and continue as before; do not double up.
  • Treatment beyond 10 days requires close monitoring of intraocular pressure, and the prescription should only be renewed by a physician after an eye examination.

Common side effects

Frequently reported tolerability concerns

  • Burning or stinging when the drops are instilled.
  • Itching of the eye.
  • Blurred or abnormal vision, usually temporary.
  • Dry eyes.
  • Chemosis (swelling of the surface of the eye).
  • Tearing (epiphora).
  • Discharge from the eye.
  • Sensation of a foreign body in the eye.
  • Photophobia (discomfort in bright light).
  • Headache.

Serious side effects

Findings that may require urgent assessment

Serious side effects require immediate discussion with the prescriber or emergency care.

  • Elevated intraocular pressure, which can progress to glaucoma with optic nerve damage and vision loss if not monitored.
  • Cataract formation (including posterior subcapsular cataract) with prolonged use.
  • Increased risk of secondary eye infection, including reactivation or worsening of herpes simplex, fungal, or bacterial eye infections, because the drug can suppress the eye's normal defenses.
  • Corneal or scleral perforation in patients whose eye tissue is already thinned by disease.
  • Corneal ulcer or bacterial keratitis.
  • Visual field defect.
  • Severe allergic reaction, including facial swelling.

Use with caution

Situations requiring closer assessment

  • Should be used with caution, and only under close monitoring, in patients with glaucoma or elevated intraocular pressure.
  • Should be used with great caution in patients with a history of herpes simplex eye infection.
  • Caution is advised in soft contact lens wearers, since the preservative can be absorbed by the lens and cause discoloration.
  • Use with caution in any persistent corneal ulceration, since fungal infection may coincidentally develop with long-term steroid use.

Contraindications

Situations where therapy may be inappropriate

  • Contraindicated in suspected or confirmed viral eye infections, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella.
  • Contraindicated in untreated bacterial eye infection.
  • Contraindicated in mycobacterial eye infection.
  • Contraindicated in fungal disease of the ocular structures.
  • Contraindicated in patients with known hypersensitivity to loteprednol etabonate, any ingredient in the formulation, or other corticosteroids.

Drug interactions

Clinically relevant combinations

  • No formal drug interaction studies have been conducted with loteprednol etabonate, and no drug-drug interactions are established.
  • The preservative benzalkonium chloride can be absorbed by and discolour soft contact lenses, so the drops should not be used while lenses are in place.
  • If another eye medication is being used, wait at least 10 minutes between products so one does not wash out the other.

Food interactions

Meal-related administration

  • No food interactions are expected, as this is an eye drop that is not swallowed or systemically absorbed to a clinically relevant degree.

Time of administration

Practical scheduling

  • Instill one drop into the affected eye(s) four times daily, at evenly spaced intervals, for up to 14 days; may be used at any time of day as directed.
  • Wait at least 10 to 15 minutes after instilling the drops before inserting soft contact lenses, and do not wear contact lenses if the eye is red.

Storage

Product handling

  • Store upright between 15 and 25 degrees C; do not freeze.
  • Once opened, discard the bottle after 28 days.
  • Keep out of reach of children, and do not let the dropper tip touch any surface to avoid contamination.

Patient take-away

Key counselling points for a quick closing summary

  • Alrex is a short-term eye drop used to relieve itching and redness from seasonal allergic conjunctivitis, usually for no more than two weeks.
  • Shake well and instill one drop into the affected eye(s) four times a day, exactly as directed by the prescriber.
  • Common effects include burning or stinging, itching, dryness, tearing, blurred vision, or sensitivity to light.
  • Contact the prescriber promptly if vision changes worsen, eye pain develops, or redness/itching fails to improve or worsens after two days, since these can signal infection or a pressure problem needing evaluation.
  • Wait 10 to 15 minutes after using the drops before inserting soft contact lenses, and avoid wearing lenses while the eye is red.
  • Store the bottle upright at room temperature, out of reach of children, and discard it 28 days after opening.

References

Source material and product information

  1. Health Canada Product Monograph — Loteprednol Etabonate

For professional reference. Confirm patient-specific decisions against the current approved product monograph and applicable clinical guidance.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.